Encompass Health Corporation
EHC
$121.54
$0.250.21%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.31% | 11.74% | -5.17% | 1.42% | 28.42% |
| Total Depreciation and Amortization | 1.54% | -0.51% | 7.54% | 3.70% | 0.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.97% | 38.40% | 15.40% | -26.74% | 35.85% |
| Change in Net Operating Assets | -367.86% | -91.38% | 375.42% | -637.50% | 81.40% |
| Cash from Operations | 3.52% | 4.11% | 23.18% | -8.96% | 18.81% |
| Capital Expenditure | 17.92% | -34.71% | 5.99% | -12.55% | 34.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 192.00% | 64.29% | -833.33% | -115.46% | 169.44% |
| Cash from Investing | 22.19% | -26.13% | -1.96% | -22.13% | 37.67% |
| Total Debt Issued | 100.00% | 100.00% | -- | -100.00% | -- |
| Total Debt Repaid | 31.86% | 24.98% | -1,193.39% | 75.80% | -719.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -592.00% | -10.29% | 59.52% | -38.84% | -12,000.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.88% | -13.33% | -0.67% | 6.29% | -6.71% |
| Other Financing Activities | -3.85% | -152.85% | 1,372.41% | 53.97% | -43.18% |
| Cash from Financing | 13.59% | -68.60% | -80.44% | -22.17% | -35.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.60% | -551.19% | 78.72% | -86.28% | 285.14% |